Safety and Efficacy of Crizotinib in ALK-Positive Lymphomas: A Phase 1b Open-Label Study

被引：0
|
作者：
Gambacorti-Passerini, Carlo
Orlov, Sergey
Zhang, Li
Braiteh, Fadi
Huang, Huiqiang
Esaki, Taito
Horibe, Keizo
Ahn, Jin-Seok
Beck, Joseph T.
Edenfield, William Jeffrey
Shi, Yuankai
Taylor, Matthew
Tamura, Kenji
Van Tine, Brian A.
Wu, Shang-Ju
Paolini, Jolanda
Li, Sherry
Kim, Tae Min
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4128
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
    Gambacorti-Passerini, Carlo
    Orlov, Sergey
    Zhang, Li
    Braiteh, Fadi
    Huang, Huiqiang
    Esaki, Taito
    Horibe, Keizo
    Ahn, Jin-Seok
    Beck, Joseph T.
    Edenfield, William Jeffrey
    Shi, Yuankai
    Taylor, Matthew
    Tamura, Kenji
    Van Tine, Brian A.
    Wu, Shang-Ju
    Paolini, Jolanda
    Selaru, Paulina
    Kim, Tae Min
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 607 - 614
  • [2] Efficacy and safety of crizotinib for treatment of ALK-positive NSCLC: a meta-analysis
    Du, Xing
    Zheng, Xiaoli
    Wang, Pengcheng
    Wang, Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 11763 - 11771
  • [3] Crizotinib Versus Chemotherapy On ALK-positive NSCLC: A Systematic Review of Efficacy and Safety
    Wang, Mingxia
    Wang, Guanqi
    Ma, Haiyan
    Shan, Baoen
    CURRENT CANCER DRUG TARGETS, 2019, 19 (01) : 41 - 49
  • [4] Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
    Wang, Xicheng
    Zhou, Jianfeng
    Li, Yan
    Ge, Yuping
    Zhou, Yanping
    Bai, Chunmei
    Shen, Lin
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2020, 12 : 21 - 33
  • [5] Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
    Solomon, Benjamin J.
    Bauer, Todd M.
    Mok, Tony S. K.
    Liu, Geoffrey
    Mazieres, Julien
    de Marinis, Filippo
    Goto, Yasushi
    Kim, Dong-Wan
    Wu, Yi-Long
    Jassem, Jacek
    Lopez, Froylan Lopez
    Soo, Ross A.
    Shaw, Alice T.
    Polli, Anna
    Messina, Rossella
    Iadeluca, Laura
    Toffalorio, Francesca
    Felip, Enriqueta
    LANCET RESPIRATORY MEDICINE, 2023, 11 (04): : 354 - 366
  • [6] Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study
    Shi, Yuankai
    Hu, Xingsheng
    Li, Xingya
    Gong, Caifeng
    Wang, Ke
    Li, Yongsheng
    Zhang, Shucai
    Luo, Yongzhong
    Wang, Pingli
    Jiang, Liyan
    Meng, Xiangjiao
    Dong, Xiaorong
    Wang, Huijuan
    Yang, Runxiang
    Mei, Qi
    Liu, Baogang
    Yang, Limin
    Sun, Yinghui
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (06) : 898 - 911
  • [7] ALK-positive large B-cell lymphomas: A clinicopathologic study
    Chandramohan, Jagan
    Ganapule, Gautami
    Sigamani, Elanthenral
    George, Biju
    Korula, Anu
    Manipadam, Marie T.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (02) : 381 - 386
  • [8] Efficacy and safety of ensartinib in ALK-positive non-small cell lung cancer patients with brain metastases: A multicenter, open-label, single-arm, phase II study
    Chang, J.
    Wu, X.
    Guo, L.
    Zhang, T.
    Fu, C.
    Huang, S.
    Jiang, G.
    ANNALS OF ONCOLOGY, 2023, 34
  • [9] Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC
    Kim, Dong-Wan
    Gadgeel, Shirish
    Gettinger, Scott N.
    Riely, Gregory J.
    Oxnard, Geoffrey R.
    Mekhail, Tarek
    Schmid, Peter
    Dowlati, Afshin
    Heist, Rebecca S.
    Wozniak, Antoinette J.
    Singh, Jatinder
    Cha, Edward
    Spahn, Jessica
    Ignatius, Sai-Hong
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (08):
  • [10] A PHASE 1B, OPEN-LABEL STUDY OF MAVORIXAFOR IN PATIENTS WITH CHRONIC NEUTROPENIC DISORDERS
    Warren, Julia
    Walkovich, Kelly
    Bolyard, Audrey Anna
    Dickerson, Kathryn
    Walter, Jolan
    Cadavid, Diego
    Chapa, Eloisa
    Chen, Kelly
    Dubuc, Susan
    MacLeod, Richard
    Peters, Katie
    Polisson, Richard
    Dale, David
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S128 - S129
12345